ArticleJournal for immunotherapy of cancer2015

Cetuximab ameliorates suppressive phenotypes of myeloid antigen presenting cells in head and neck cancer patients.

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.